Health TrialsbyHealthPanel

Private-sector Access to Testing for Health Sustainability

ConditionHIV Prevention
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco

About this trial

New and innovative strategies are urgently needed to increase the uptake of HIV prevention and sexual and reproductive health services among adolescent girls and young women (AGYW) in sub-Saharan Africa. To ensure the real-world sustainability of free distribution of HIV self-test kits to AGYW by private drug shops and pharmacies, investigators will rigorously test supply-side subsidy structures for shopkeepers' provision of HIV-self test kits to AGYW combined with prosocial motivational supports. The combination of non-monetary and monetary support structures aims to emulate real-world health financing models for public-private partnerships and ultimately aims to improve equity in access to critical prevention services for AGYW at scale.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Owners/staff of retail drug shops and pharmacies located in the study regions

Age 18 and older

Disqualifiers

Refusal to install and track sales and distribution of HIVST kits using the Maisha Meds data system provided.

Trial design

Design model

Single group

Treatments tested in this trial

  • Low HIVST kit subsidy

    Behavioral

    The two study groups are the "high" and "low" subsidy groups. The high subsidy group will start off with a 90% subsidy while the low subsidy group will start off with a 50% subsidy. Both study groups will experience decreasing subsidies at each phase of the study.

  • High HIVST kit subsidy

    Behavioral

    The two study groups are the "high" and "low" subsidy groups. The high subsidy group will start off with a 90% subsidy while the low subsidy group will start off with a 50% subsidy. Both study groups will experience decreasing subsidies at each phase of the study.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: High subsidyExperimental treatment 1 intervention
Group B: Low subsidyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Number of HIVST kits distributed to AGYW per shop month

HIVST kit distribution per shop per month will be tracked via Maisha Meds sales and inventory management system. The data from Maisha Meds will include a tag that identifies the kit recipient as an AGYW and will include the price paid for the HIVST kit ($0 for AGYW).

Time frame
39 months

Secondary outcomes

1

Adoption

Proportion of shops continuing to procure HIVST kits throughout the study

Time frame
39 months
2

Implementation 1

Proportion of shops that offer free HIVST to AGYW mystery client actors

Time frame
39 months
3

Implementation 2

Proportion of shops continuing to provide free HIVST throughout the study period

Time frame
39 months
4

Implementation 3

Shopkeeper perspectives on challenges and successes related to providing HIVST kits free to AGYW as measured via surveys and in-depth interviews.

Time frame
39 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of California, San Francisco

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator

Muhimbili University of Health and Allied Sciences

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: